Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole in CLL with yeast/mold-reactive stereotypic B-cell receptors
NL-OMON36874Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of posaconazole in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and monoclonal B cell lymphocytosis (MBL), sponsored by Amsterdam University Medical Center. Primary endpoints: Decrease in clone size and Decrease in activation status of CLL cells. Planned start Jul 2012; status: withdrawn.
02
Drugs
posaconazole
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)monoclonal B cell lymphocytosis (MBL)
Beyond the preview
Go deeper on NL-OMON36874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36874.